Benzinga's Top #PreMarket Losers

Retrophin RTRX shares declined 6.82% to $11.00 in pre-market trading following the announcement of temporary halt of RE-024 patient dosing. Isis Pharmaceuticals ISIS dipped 3.82% to $34.99 in pre-market trading after gaining 0.78% on Thursday. The decline in the stock may be attributed to Seeking Alpha article. E. I. du Pont de Nemours and Company DD fell 2.95% to $65.70 in pre-market trading after the company cut its profit guidance for the second-quarter and year. AmSurg AMSG dropped 1.11% to $45.29 in pre-market trading after the company priced 8.5 million share offering at $45.00 per share. Baird upgraded Amsurg from Neutral to Outperform and raised the price target from $44.00 to $55.00.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsMovers & ShakersPre-Market OutlookMarketsTop Losers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!